Literature DB >> 16186801

Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation.

M T Pickering1, T F Kowalik.   

Abstract

Although it is unclear which cellular factor(s) is responsible for the genetic instability associated with initiating and sustaining cell transformation, it is known that many cancers have mutations that inactivate the Rb-mediated proliferation pathway. We show here that pRb inactivation and the resultant deregulation of one E2F family member, E2F1, leads to DNA double-strand break (DSB) accumulation in normal diploid human cells. These DSBs occur independent of Atm, p53, caspases, reactive oxygen species, and apoptosis. Moreover, E2F1 does not contribute to c-Myc-associated DSBs, indicating that the DSBs associated with these oncoproteins arise through distinct pathways. We also find E2F1-associated DSBs in an Rb mutated cancer cell line in the absence of an exogenous DSB stimulus. These basal, E2F1-associated DSBs are not observed in a p16(ink4a) inactivated cancer cell line that retains functional pRb, unless pRb is depleted. Thus, Rb status is key to regulating both the proliferation promoting functions associated with E2F and for preventing DNA damage accumulation if E2F1 becomes deregulated. Taken together, these data suggest that loss of Rb creates strong selective pressure, via DSB accumulation, for inactivating p53 mutations and that E2F1 contributes to the genetic instability associated with transformation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16186801     DOI: 10.1038/sj.onc.1209103

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

2.  E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.

Authors:  M E Crosby; J Jacobberger; D Gupta; R M Macklis; A Almasan
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

Review 3.  RB: mitotic implications of a tumour suppressor.

Authors:  Amity L Manning; Nicholas J Dyson
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

4.  ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Authors:  Awad Shamma; Misa Suzuki; Naoyuki Hayashi; Masahiko Kobayashi; Nobunari Sasaki; Takumi Nishiuchi; Yuichiro Doki; Takahiro Okamoto; Susumu Kohno; Hayato Muranaka; Shunsuke Kitajima; Ken-Ichi Yamamoto; Chiaki Takahashi
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

5.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

6.  A tool for enhancement and scoring of DNA repair foci.

Authors:  Bogdan I Gerashchenko; Joseph R Dynlacht
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

Review 7.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

8.  Loss of RBF1 changes glutamine catabolism.

Authors:  Brandon N Nicolay; Paulo A Gameiro; Katrin Tschöp; Michael Korenjak; Andreas M Heilmann; John M Asara; Gregory Stephanopoulos; Othon Iliopoulos; Nicholas J Dyson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

9.  The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.

Authors:  Shuhua Yi; Heng Li; Zengjun Li; Wenjie Xiong; Huimin Liu; Wei Liu; Rui Lv; Zhen Yu; Dehui Zou; Yan Xu; Gang An; Lugui Qiu
Journal:  Int J Hematol       Date:  2017-04-24       Impact factor: 2.490

10.  E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.

Authors:  Dexi Chen; Zhiyong Yu; Zhiyi Zhu; Charles D Lopez
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.